Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Keyphrases

• Treatment Duration 100%
• Vitamin K Antagonists 100%
• Recurrent Venous Thromboembolism 100%
• Venous Thromboembolism 25%
• Prolonged Treatment 25%
• Major Bleeding 12%
• Meta-analysis 12%
• Selection Criteria 12%
• MEDLINE 12%
• Embase 12%
• Bleeding Risk 12%
• Randomized Controlled Clinical Trial 12%
• Cochrane Library 12%
• Search Strategy 12%
• Cochrane 12%
• Peripheral Vascular Disease 12%
• Bleeding Complications 12%
• Oral Anticoagulants 12%
• Cochrane Central Register of Controlled Trials 12%
• Disease Groups 12%
• Thrombotic Events 12%
• Absolute Risk 12%
• Electronic Search 12%
• Recurrent Events 12%
• Issue 3 12%
• Secondary Treatment 12%
• Rebound Phenomenon 12%

INIS

• vitamin k 100%
• risks 87%
• patients 75%
• data 25%
• reduction 12%
• comparative evaluations 12%
• safety 12%
• clinical trials 12%
• reviews 12%
• administration 12%
• libraries 12%
• range 12%
• vascular diseases 12%
• anticoagulants 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Venous Thromboembolism 100%
• Antivitamin K 100%
• Bleeding 37%
• Anticoagulant Agent 12%
• Recurrent Disease 12%
• Controlled Clinical Trial 12%
• Peripheral Vascular Disease 12%